Biocore® M-BCR-ABL1 p210 PCR kit: quantification of b2a2 and b3a2

Biocore® M-BCR-ABL1 p210 b2a2, b3a2 quantification — RT-PCR-RF test— a system for the quantitative determination of the b2a2 and b3a2 transcripts of the BCR-ABL1 gene translocation product (Philadelphia chromosome, p210 type) from the Ukrainian developer Biocore Technology. The kit is intended for the initial diagnosis and quantitative monitoring of CML and Ph+ ALL, with a combined quantitative determination of the most common transcripts — b3a2 (e14a2, ~55–60% of cases) and b2a2 (e13a2, ~35–40% of cases). Registered name: ‘Biocore® M-BCR-ABL1 p210 b2a2, b3a2 Quantification Kit’ for the quantitative determination of the b2a2 and b3a2 transcripts of the BCR-ABL1 gene translocation by real-time RT-PCR Catalogue number: SM-M-BCRABL1 602-100

Product expert helpline: call +380444927270 (Extension 3463).